Published in PLoS Pathog on January 16, 2014
Trained immunity: A program of innate immune memory in health and disease. Science (2016) 1.43
Regulation of inflammasome activation. Immunol Rev (2015) 1.28
Mechanisms of inflammasome activation: recent advances and novel insights. Trends Cell Biol (2015) 1.20
Hemolysis-induced lethality involves inflammasome activation by heme. Proc Natl Acad Sci U S A (2014) 1.20
Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev (2015) 1.18
Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux. J Immunol (2015) 1.05
The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation. J Cell Biol (2016) 0.98
Non-Inflammasome Forming NLRs in Inflammation and Tumorigenesis. Front Immunol (2014) 0.96
Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome components. Oncotarget (2015) 0.87
NLR proteins and parasitic disease. Immunol Res (2014) 0.86
Emerging significance of NLRs in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.86
Parasite virulence, co-infections and cytokine balance in malaria. Pathog Glob Health (2014) 0.84
Beyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory disease. Semin Immunopathol (2014) 0.81
The NLRP3 inflammasome and stroke. Int J Clin Exp Med (2015) 0.80
Exacerbation of autoimmune neuro-inflammation in mice cured from blood-stage Plasmodium berghei infection. PLoS One (2014) 0.80
Splenic Macrophage Subsets and Their Function during Blood-Borne Infections. Front Immunol (2015) 0.79
A Fluorescent Reporter Mouse for Inflammasome Assembly Demonstrates an Important Role for Cell-Bound and Free ASC Specks during In Vivo Infection. Cell Rep (2016) 0.78
How Mouse Macrophages Sense What Is Going On. Front Immunol (2016) 0.78
Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis. Semin Immunopathol (2014) 0.77
Holding the inflammatory system in check: NLRs keep it cool. F1000Prime Rep (2015) 0.77
Berberine affects osteosarcoma via downregulating the caspase-1/IL-1β signaling axis. Oncol Rep (2016) 0.76
Inflammasomes in Myeloid Cells: Warriors Within. Microbiol Spectr (2017) 0.75
NLRP12 negatively regulates proinflammatory cytokine production and host defense against Brucella abortus. Eur J Immunol (2016) 0.75
Kaurenoic Acid Possesses Leishmanicidal Activity by Triggering a NLRP12/IL-1β/cNOS/NO Pathway. Mediators Inflamm (2015) 0.75
Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors. Cell Mol Life Sci (2016) 0.75
Innate Immune Cell Recovery Is Positively Regulated by NLRP12 during Emergency Hematopoiesis. J Immunol (2017) 0.75
Next-Generation mRNA Sequencing Reveals Pyroptosis-Induced CD4+ T Cell Death in Early Simian Immunodeficiency Virus-Infected Lymphoid Tissues. J Virol (2015) 0.75
Splenic differentiation and emergence of CCR5(+)CXCL9(+)CXCL10(+) monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun (2016) 0.75
Major transcriptional changes observed in the Fulani, an ethnic group less susceptible to malaria. Elife (2017) 0.75
The inflammasomes. Cell (2010) 19.37
Cryopyrin activates the inflammasome in response to toxins and ATP. Nature (2006) 18.74
Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol (2008) 16.65
Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol (2009) 14.33
Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity (1999) 11.64
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med (1986) 10.91
Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature (2006) 9.77
Non-canonical inflammasome activation targets caspase-11. Nature (2011) 8.85
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ (2007) 8.85
Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol (2009) 8.40
Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science (1987) 7.01
Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc (2009) 6.71
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis (2009) 5.90
The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol (2011) 5.73
Sepsis definitions: time for change. Lancet (2013) 5.63
Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science (2013) 5.06
Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood (2008) 4.63
Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med (2010) 4.52
Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J Biol Chem (2007) 4.27
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet (2007) 4.23
Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity (2011) 3.97
Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study. Lancet (2011) 3.78
Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity (2011) 3.74
The history of Toll-like receptors - redefining innate immunity. Nat Rev Immunol (2013) 3.59
Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A (2007) 3.41
PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem (2002) 3.28
Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood (2010) 3.23
Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med (2000) 3.12
Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One (2009) 2.93
Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis (2012) 2.53
Malaria biology and disease pathogenesis: insights for new treatments. Nat Med (2013) 2.38
Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci U S A (2010) 2.38
The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J Biol Chem (2005) 2.21
Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J Immunol (2010) 2.09
Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog (2009) 2.07
Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol (1996) 2.06
Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat Med (2011) 2.04
ATP-gated P2X cation-channels. Neuropharmacology (2008) 2.00
Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J Immunol (2007) 1.97
Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J (2007) 1.97
Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol (2012) 1.95
Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proc Natl Acad Sci U S A (2005) 1.95
Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J Immunol (2001) 1.82
The NLRP12 inflammasome recognizes Yersinia pestis. Immunity (2012) 1.70
Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function. Proc Natl Acad Sci U S A (2009) 1.70
Pathological role of Toll-like receptor signaling in cerebral malaria. Int Immunol (2006) 1.66
Plasmodium falciparum infection causes proinflammatory priming of human TLR responses. J Immunol (2007) 1.63
Human NLRP3 inflammasome activation is Nox1-4 independent. Blood (2010) 1.59
Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. J Exp Med (1998) 1.57
Pure Hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J Immunol (2009) 1.48
Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. Proc Natl Acad Sci U S A (2011) 1.44
Role of endogenous gamma interferon in host response to infection with blood-stage Plasmodium chabaudi AS. Infect Immun (1990) 1.40
Murine cerebral malaria development is independent of toll-like receptor signaling. Am J Pathol (2007) 1.38
Bacteremia in Kenyan children presenting with malaria. J Clin Microbiol (2010) 1.37
Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Clin Exp Immunol (1992) 1.29
Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. J Infect Dis (2008) 1.16
Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med (2013) 1.14
Induction of experimental cerebral malaria is independent of TLR2/4/9. Med Microbiol Immunol (2007) 1.06
Enhanced Toll-like receptor responsiveness associated with mitogen-activated protein kinase activation in Plasmodium falciparum-infected children. Infect Immun (2008) 1.05
Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur J Immunol (2010) 1.04
Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes. Arthritis Rheum (2011) 1.03
Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 is dispensable for induction of experimental cerebral malaria. Infect Immun (2011) 1.02
Neutrophil paralysis in Plasmodium vivax malaria. PLoS Negl Trop Dis (2012) 1.00
TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. Am J Trop Med Hyg (2010) 1.00
Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria. Infect Immun (1994) 1.00
Role of interleukin-1β in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy. Arthritis Rheum (2011) 1.00
Alterations of splenic architecture in malaria are induced independently of Toll-like receptors 2, 4, and 9 or MyD88 and may affect antibody affinity. Infect Immun (2008) 0.98
Clinical profile of concurrent dengue fever and Plasmodium vivax malaria in the Brazilian Amazon: case series of 11 hospitalized patients. Am J Trop Med Hyg (2012) 0.97
Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection. PLoS One (2010) 0.95
Pathogen sensors and chemokine receptors in dendritic cell subsets. Vaccine (2012) 0.94
Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet (1998) 0.87
Caspase-12 dampens the immune response to malaria independently of the inflammasome by targeting NF-kappaB signaling. J Immunol (2010) 0.83
The history of the malaria treatment of general paralysis. Am J Psychiatry (1946) 0.82